SU5208

CAS No. 62540-08-3

SU5208( 3-[(Thien-2-yl)methylene]-2-indolinone )

Catalog No. M22956 CAS No. 62540-08-3

SU5208 is a compound with bioactivity.SU5208 inhibits vascular endothelial growth factor receptor-2 (VEGFR2).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 268 In Stock
10MG 405 In Stock
25MG 668 In Stock
50MG 888 In Stock
100MG 1251 In Stock
500MG 2538 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SU5208
  • Note
    Research use only, not for human use.
  • Brief Description
    SU5208 is a compound with bioactivity.SU5208 inhibits vascular endothelial growth factor receptor-2 (VEGFR2).
  • Description
    SU5208 is a compound with bioactivity.SU5208 inhibits vascular endothelial growth factor receptor-2 (VEGFR2).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    3-[(Thien-2-yl)methylene]-2-indolinone
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    62540-08-3
  • Formula Weight
    227.28
  • Molecular Formula
    C13H9NOS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (439.99 mM)
  • SMILES
    O=C1NC2=C(C=CC=C2)/C1=C/C3=CC=CS3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Camila Mu?oz, et al. Study of differences in the VEGFR2 inhibitory activities between semaxanib and SU5205 using 3D-QSAR, docking, and molecular dynamics simulations. J Mol Graph Model. 2012 Feb;32:39-48.
molnova catalog
related products
  • Cabozantinib (S-mala...

    Cabozantinib (XL184) is a potent, multi-kinase inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50 of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.

  • Pz-1

    Pz-1 is an inhibitor of VEGFR2 and RET (rearranged during transfection) tyrosine kinase that blocks the blood supply required for RET-stimulated growth.

  • VEGFR2-IN-1

    VEGFR2-IN-1 is a selective and potent VEGFR2 inhibitor with antitumor activity that inhibits cell proliferation and migration and can be used in the study of breast cancer.